2Helfrich I, Chen M, Schmidt R, et al. Increased incidence of squamous cell carcinomas in Mastomys natalensis papillomavirus E6 transgenic mice during two -stage skin carcinogenesis[ J]. J Virol, 2004,78(9) :4797 -4805.
7Dybikowska A, Dettlaff A, Konopa K, et al. p53 codon 72 polymorphlsm in cervical cancer patients and healthy women from Poland[J]. Acta Bioehim Pol,2000,47(4) :1179 -1182.
8Nair P, Jayaprakash PG, Nair MK, et al. Telomerase, p53 and human papillomavirus infection in the uterine cervix[J]. Acta Oncol,2000,39( 1 ) :65 -70.
9Gewin L, Galloway DA. E box - dependent activation of telomerase by human papillomavirus type16 E6 does not require induction of c - myc[J]. J Virol,2001,75 ( 15 ) :7198-7201.
10Filippova M, Parkhurst L, Duerksen -Hughes PJ. The human papillomavirus 16 E6 protein binds to Fas - associated death domain and protects cells from Fas -triggered apoptosis[ J]. J Biol Chem, 2004,279 ( 24 ) : 25729 - 25744.
6[1]Hwang T S, Jeong J K, Park M, et al. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray[J]. Gynecol Oncol,2003,90(1) :51 - 56.
7[2]Banuelos A, Reyes E, Ocadiz R, et al. Neocarzinostatin induces an effective p53-dependent response in human papillomavirus-positive cervical cancer cells [ J ]. J Pharmacol Exp Ther,2003,306(2) :671 - 680.
8[3]Haensen G, Krause U, Becker A, et al. p53, and prognosis in cervical cancers[J]. Int J Radiation Oncol Biol Ph ys, 2001,50(4) :865 - 872.
9[4]Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer[J]. Nature, 1998,393:229 - 234.
10[5]Abba M C, Villaverde L M, Gomez M A, et al. The p53 codon 72 genotypes in HPV infection and cervical disease[J]. Eur J Obstet Gynecol Reprod Biol,2003,109( 1 ) :63 - 66.
1Shai A,Brake T,Somoza C,et al.The human Papilloma virus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities[J].Cancer Res,2007,67 (4):1626-1635.
2Xu M,Luo W,Elzi D J,et al.NFX1 interacts with mSin3A /histone deacetylase to repress hTERT transcription iratinocytes[J].Mol Cell Biol,2008,28(15):4819-4828.
3Schwartz T F,Spaczynski M,Schneider A,et al.Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years[J].Vaccine,2009,27:581-587.
4Xu Y F.HPV16 chimeric virus-like particle vaccine with mLTK63adjuvant[J].Basic Clini Med,2008,in press.
5Mark R P,Trent H,Roger D P,et al.Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response[J].PNAS,2006,103(10):3822-3827.
